Equities

International Isotopes Inc

INIS:QBB

International Isotopes Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.035
  • Today's Change0.00 / 0.00%
  • Shares traded74.00k
  • 1 Year change-29.15%
  • Beta0.4776
Data delayed at least 15 minutes, as of Sep 19 2024 18:43 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year International Isotopes Inc had net income fall from a gain of 303.24k to a loss of 869.02k despite a 9.71% increase in revenues from 11.18m to 12.27m.
Gross margin62.94%
Net profit margin-6.96%
Operating margin-6.97%
Return on assets-5.32%
Return on equity-20.92%
Return on investment-7.76%
More ▼

Cash flow in USDView more

In 2023, International Isotopes Inc increased its cash reserves by 10.98%, or 353.02k. The company earned 582.59k from its operations for a Cash Flow Margin of 4.75%. In addition the company used 149.06k on investing activities and also paid 80.50k in financing cash flows.
Cash flow per share-0.0009
Price/Cash flow per share--
Book value per share0.0073
Tangible book value per share-0.0019
More ▼

Balance sheet in USDView more

International Isotopes Inc has a Debt to Total Capital ratio of 33.78%, a lower figure than the previous year's 119.80%.
Current ratio0.6466
Quick ratio0.5424
Total debt/total equity0.5102
Total debt/total capital0.3378
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.